Minerva Neurosciences
NERV
35 hedge funds and large institutions have $16.6M invested in Minerva Neurosciences in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 14 closing their positions.
307% more call options, than puts
Call options by funds: $366K | Put options by funds: $90K
9.21% less ownership
Funds ownership: 57.77% → 48.57% (-9.2%)
24% less funds holding
Funds holding: 46 → 35 (-11)
61% less capital invested
Capital invested by funds: $42.9M → $16.6M (-$26.3M)
69% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 16
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$68.5K |
| 2 |
AC
Armistice Capital
New York
|
+$28.2K |
| 3 |
Millennium Management
New York
|
+$23.5K |
| 4 |
BlackRock
New York
|
+$21.3K |
| 5 |
Jane Street
New York
|
+$12.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.88M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$848K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$836K |
| 4 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$696K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$459K |
NERV Hedge Fund Activity: Q4 2021 in Review
35 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2021, worth a combined $16.6M — down 61% from $42.9M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NERV and 3 opened new positions — a net loss of 11 holders — while 16 trimmed existing stakes and 5 added.
The largest buyer was Acadian Asset Management, adding an estimated $68.5K. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $1.88M sold.
- 35 institutional investors held Minerva Neurosciences (NERV) as of Q4 2021, down from 46 in Q3 2021.
- Funds reported $16.6M of Minerva Neurosciences stock for Q4 2021, down 61% quarter-over-quarter.
- 3 funds opened new Minerva Neurosciences positions in Q4 2021 and 14 closed out, a net change of -11 holders.
- The largest Minerva Neurosciences buyer in Q4 2021 was Acadian Asset Management, an estimated $68.5K added.
- The largest Minerva Neurosciences seller in Q4 2021 was Assenagon Asset Management, an estimated $1.88M sold.
Based on aggregated 13F filings for Q4 2021.